Organization: Canadian Bacterial Diseases Network

Bioniche projects receive $17.6 million from TPC

Bioniche Life Sciences Inc has received $17.2 million from Technology Partnerships Canada (TPC) for two R&D projects that will create nearly 600 jobs in Belleville ON. TPC is providing $7.6 million to the first project targeting a vaccine to reduce E.coli bacteria in cattle. The second project will receive $9.6 million to develop mycobacterial cell…

CBDN signs deal with Novartis Animal Health

The Canadian Bacterial Diseases Network (CBDN) has signed license and collaborative research agreements with Novartis Animal Health Inc, Basel Switzerland, for a vaccine to prevent shipping fever in cattle. The vaccine is being developed by CBDN in conjunction with the Univ of Calgary, Univ of Guelph and the Veterinary Infectious Diseases Organization, Saskatoon. CBDN concluded…